Advances in Medicinal and Pharmaceutical Chemistry AMPC-2019

A licensed pharmacist with a background in Immunology research, Elena Mascia is a Sapienza University of Rome honor graduate. Following her MSc in Pharmaceutical Chemistry, in 2016 Elena collaborated with the Immunoregulation unit of Pasteur Institute in Paris. For the past 3 years Elena Mascia has been working for Skillpharma, a consultancy firm in the health sector. As a Pharmacovigilance Specialist and a GVP Quality Assurance, Elena has experience in working for both small and big Pharma companies, monitoring the safety of medicinal products and aiming to an early detection of any changes to their risk-benefit ratio. Currently, Elena is also involved in Pharmaceutical training activities as a lecturer for Res Excelsa, a company that provides high-level training and executive consulting

Asaf Evrim EVREN is a pharmacist. He works at Bilecik Şeyh Edebali University as an academician since 2019, March. He holds a BSc degree in pharmacy and a MSc degree in Pharmaceutical Chemistry. Also, he is currently PhD student at Pharmaceutical Chemistry at Anadolu University. He has 3 articles which are themed Pharmaceutical Chemistry at SCI and SCI-Expanded journals. Additionally, he has 10 conference papers which were presented at international scientific meetings and published in proceedings. He shows interest to some aromatic rings such as thiazole, imidazole triazole, benzimidazole, benzothiazole, benzofuran and quinoline, and also some non-aromatic rings like piperazine and piperidine.

Derya Osmaniye is a research assistant at Anadolu University Faculty of Pharmacy, Department of Pharmaceutical Chemistry. She has completed her master’s degree in 2017. She is doing her Ph.D. now and is in the fifth semester of Ph.D. She has published more than 20 papers in reputed journals and has delivered more than 50 poster presentations to date. Synthesis of new enzyme inhibitor, antifungal, anticancer candidates, analysis studies (IR, NMR, HRMS) constitutes her main research area. Benzimidazole, benzothiazole, benzoxazole, thiazole, oxadiazole, triazole, thiadiazole, Schiff bases, catalytic reduction, and hydrazine are some of the applications in the field of study.

Abdul Mannan Fateh currently studying Ph.D. student (last year) in pharmacology department in the faculty of medicine in University Malaya in Malaysia. He has completed his Master degree (M.SC.) in toxicology. DEP. Medical sedimentology & toxicology, Hamdard university (new – Delhi) India. He has worked in medical college from 2008 –2013 in Yemen as a lecturer in Toxicology. He has published 4 Research Publications in well-reputed ISI journals Q1&Q2 and high impact factor. Participant in two international conferences at Oslo, Norway & Malaysia.

Begüm Nurpelin Sağlık graduated from Anadolu University Faculty of Pharmacy in 2014. She has completed her master’s degree in 2016 and her PhD degree on September 2019 in Anadolu University Faculty of Pharmacy, Department of Pharmaceutical Chemistry. She has published more than 40 articles in reputed journals and has delivered more than 60 poster and oral presentations to date. Synthesis of new enzyme inhibitor candidates, investigation of enzyme inhibition assays (acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A and B, cyclooxygenase 1 and 2), antifungal and anticancer screenings and molecular docking studies constitutes her main research area. She is still working as a research assistant in Anadolu University Faculty of Pharmacy, Department of Pharmaceutical Chemistry.

Lixue Lu is currently a postgraduate in the Department of Medicinal Chemistry at China Pharmaceutical University (Nanjing, China). Lixue Lu mainly focuses on the chemical modification of a pentacyclic triterpenoid natural product 23-hydroxy botulinic acid

Wen Shuai is currently a postgraduate in the Department of Medicinal Chemistry at China Pharmaceutical University (Nanjing, China). Her research focus on the design and synthesis of novel microtubule-inhibitor agents and novel tyrosinase inhibitors, which has published 8 peer-reviewed journal articles. She is passionate about acquiring the latest advances in medicinal chemistry via various medicinal chemistry conferences.

Seasoned pharmacist and researcher in education and learning sector with work experience of nearly 2 decades, including industrial experience at Ranbaxy Research Laboratories and Smart Analyst Inc. Providing provision of a range of high-quality undergraduate and postgraduate programs which meet the needs of students. Enducing innovation in teaching and learning and curriculum design. Working as an interface between the management and the entire teaching and learning staff, instrumental in embedding consistent and effective policies and Procedures across all departments. The lead practitioner who challenges the current systems and processes and inspires the entire staff to provide innovative solutions to learning. Currently a student of Law and working on Pharmacy law and Patent law.

My goal is to promote the science of laser medicine for the health of the people of the world. Ehsan Kamani was born in 1994 in Iran. I am a graduate of the field of optics and laser engineering and have credible evidence of laser application in medicine. I began researching from a student day about the use of laser in cancer-using laser in the proliferation of laser-use cells in depression- Application of hematologic laser.

Kathleen Walter is a nutritional immunologist from North Carolina, United States. She received her Ph.D. in Animal Science from North Carolina State University. Kathleen has 6 years of experience in graduate-level research. She studies the roles of dietary polyunsaturated fatty acids and their effects on the innate immune response to respiratory pathogens; with a specialty in using neonatal pigs as a model for human and agricultural applications. She has presented more than 9 abstracts at international and domestic conferences including Experimental Biology, American Society for Nutrition, In Vitro Biology, and The New York Academy of Sciences STEM Exchange: Research and Career Symposium.

Dr. Farid Menaa (Bsc. Eng., Bsc. Bio., Msc. Genetics, Master Gerontology/Geriatry, PhD Radiation Oncology and Gerontology, EMBA Entrepreneurship and MD candidate), is an inter- and multi-disciplinary professional. Professor, Principal Investigator, Director, Consultant Editor, Reviewer, Event Organizer and Entrepreneur, Dr. Menaa earned his degrees with highest distinctions from prestigious French universities and institutions. Dr. Menaa followed a post-doctoral in Oncology as a NIH-fellow (San Diego, California, USA; 2004-2007). Subsequently, Dr. Menaa pursed his career in Dermatology, and Stem Cells as a DFG-Fellow (Wuerzburg, Germany; 2007–2009). Then, Dr. Menaa was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, Dr. Menaa was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (São Paulo, Brazil; 2010–2012). During his career, Dr. Menaa also followed complementary formations (e.g. Medecine, Pharmacy, Biochemistry, Biophysics, Food Sciences and Technology, Marine Biology, Nano-Biotechnology, Bio-Computation, Bio-Statistics, Business Development and Management, Technological Innovation and Quality). Overall, Dr. Menaa was involved in various R&D projects in multiple areas of medicine/nanomedicine, pharmacy/pharmacology/toxicology, biology, stem cells/tissue engineering, genetics/genomics, fluorine chemistry/biochemistry, biophysics/biophotonics, food science, technology/nanotechnology, and business). His main current focuses are related to preventive, personalized, translational, integrative and nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy. Dr. Menaa has a strong experience with teaching, research and development, supervision, edition, leadership, coaching, consulting, event organizations, scientific & medical collaborations in several countries. Dr. Menaa is, among others, the leading organizer of the Target Meeting´s 1st World Nanomedicine and Nanobiotechnology Online Conference 2013 (http://www.targetmeeting.com), co-organizer of “Nanomaterials Conference” 2013 (Beijing, China) and 2014 (Shenzhen, China), member of the technical committee of the “3rd ScienceOne Conference on Drug Discovery and Development” 2014 (Dubai, UAE). Dr. Menaa is a member of several prestigious organizations (medical and scientific societies), editor, guest editor and reviewer of a large number of esteemed journals worldwide (>50) (e.g. Current Medicinal Chemistry, International Journal of Nanomedicine, Current Organic Chemistry). Among them, he sits on the prestigious editorial boards of Current Drug Therapy (for which is also the lead guest editor of a special issue on nano-pharmaceuticals), Journal of Nanomaterials & Molecular Nanotechnology (JNMN) (for which he is also a guest editor of a special issue on graphene), Journal of Biomaterials and Nanobiotechnology (JBNB), and Journal of Nanomedicine and Biotherapeutics Discovery (JNBD). Dr. Menaa authored and co-authored more than 100 publications (including peer-reviewed ISI research and review articles, books, book chapters, conference proceedings, patents). Dr. Menaa is often invited as a speaker, keynote/featured speaker and (co-)chairman to reputed world congresses and institutions, where he is offering speeches in various areas of medicine, sciences and technology. During his spare time, Dr. Menaa enjoys family, arts, sports and travelling

Neetu Agrawal is an Assistant Professor in the department of Pharmaceutical Chemistry, GLA University, Mathura (U.P.), India. She has five years of teaching and research experience and recently submitted her PhD thesis in Pharmaceutical Science entitled as ‘Synthesis and Biological Evaluation of some Isoxazoles’. She has been actively involved in the research in medicinal chemistry and has published seven research papers in SCI-indexed journals. She is interested in rearch related to computer-aided drug designing. She was awarded gold medal for holding first rank in the University for her master’s degree.

Dr Tarek Mohamed Kamal Mohamed Metawie, Professor of Biochemistry, Faculty of Pharmacy, Cairo University. Egyptian, date of birth 6/3/1955. Ph.D. in Pharmaceutical Sciences, 1984; M.Sc. in Pharmaceutical Sciences, 1979; B.Sc. in Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University, 1976.

Dr. Blondino has over 20 years of broad based drug development experience in parenteral, oral liquid, and inhalation products. He is currently the Director of Drug Development at Kaleo, Inc. in Richmond, Virginia. He has held industrial positions

Prakash Diwan obtained his PhD from Postgraduate Institute of Medical Education and Research, Chandigarh, India. Contributed in the areas of Novel Drug Delivery systems & drug discovery. Published over 200 papers in pre-reviewed journals. He delivered gue